A cross sectional study of psoriasis and its association with lipid profile among the patients in a tertiary care centre

https://doi.org/10.53730/ijhs.v6nS1.8498

Authors

  • Bhagyashree Kanakareddi Assistant Professor, Department of Dermatology, Gadag Institute of Medical Sciences, Gadag, Karnataka
  • Jitendra L Chukkanakal Senior Resident, Department of Pediatrics, Gadag Institute of Medical Sciences, Gadag, Karnataka
  • Athresh Kanamukkalu Narayanamurthy Junior Resident, Vasavi Hospital, Bangalore
  • Pradeep Senapathi Associate Professor, Department of Community Medicine, A.J. Institute of Medical Sciences and Research Centre, Mangalore

Keywords:

Lipid Profile, Psoriasis, Cholesterol, Skin Disease

Abstract

Background: One of the most prevalent dermatological disorders seen in everyday practise is psoriasis. There has been a lot of new study on it being considered a systemic disease, with experts believing that the dermatological indications are only a small portion of the picture. Psoriasis is linked to aberrant lipid profiles, elevated fasting blood glucose levels, increased waist circumference, and elevated blood pressures, all of which are symptoms of the metabolic syndrome. Objectives: To study the serum lipid Profile among Psoriasis patients attending out patient Department in a tertiary care hospital. Materials and Methods: The Present cross sectional study was conducted by the Department of Dermatology at Gadag Institute of Medical Sciences from January 2021 to December 2021. A total of 50 study subjects were enrolled for the purpose of the study. After obtaining informed consent, a detailed history including demographic data, drug history, personal history, family history, present and past medical history, emotional stress and exposure to Sexually transmitted diseases were taken. Results: The mean age of the study subjects was found to 39.21+15.3 years of age in the present study majority (80%) of them were males and 20% were females.

Downloads

Download data is not yet available.

References

Baker H. Psoriasis a review. Dermatologica. 1975; 150: 16-25.

Linden KG, Weinstein GD. Psoriasis: current perspectives with an emphasis on treatment. Am J Med.1999; 107: 595-605.

Mallbris L, Larsson P, Bergquist S, Vingard E, Granath F, Stahle M. Psoriasis phenotype at disease onset: Clinical characterization of 400 adult cases. J Invest Dermatol. 2005;124:499-504.

Griffiths CEM, Camp RDR, Barker JNWN. Psoriasis. In: Rook‟s Textbook of Dermatology. Burns T, Breathnach S, Cox N, Griffiths C editors. 7thedition. Blackwell Science, Oxford 2005; pp. 35.1- 35.69.

Michael P, Schon W, Boehncke H. Psoriasis. New Eng J Med. 2005; 352: 1899-912

Raychaudhari SP, Run G, Farber EM. Neuropathogenesis and neuropharmacology of psoriasis. Int J Dermatol. 1995; 34: 685-93.

Seishima M, Mori S, Noma A. Serum lipid and apolipoprotein levels in patients with psoriasis. Br J Dermatol. 1994;130:738-42.

Seckin D, Tokgozoglu L, Akkaya S. Are lipoprotein profile and lipoprotein a levels altered in men with psoriasis? J Am Acad Dermatol. 1994; 31: 445-449.

Javidi Z, Meibodi NT, Nahidi Y. Serum lipid abnormalities and psoriasis. Indian J Dermatol. 2007; 52: 89-92.

Wakkee M, Thio HB, Prens EP, Sijbrands EJG, Neumanna HAM. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis. 2007; 190: 1-9.

Torkhovskaia TI, Fortinskaia ES, Ivanova LI, Nikitina NA, Zakharova TS, Kochetova MM, et al. characteristics of lipid transport system in psoriasis. Vopr Med Khim. 2002; 48:297-303.

Kaur I, Kumar B, Sharma VK . Epidemiology of psoriasis in a clinic from North India. Indian J Dermatol Venereol Leprol. 1986; 52: 208-21.

Mehta TK, Shah RN, Marquis LA. A study of 300 cases of psoriasis. Indian J Dermatol Venereol Leprol. 1976; 42(2): 67-9.

Kremers HM, McEvoy MT, Dann FJ, Gabriel SE. Heart disease in psoriasis. J Am Acad Dermatol. 2007; 57:347-54.

Koba S, Hirano T, Sakaue T, Takeuchi H, Adachi M, Katagiri T. An increased number of very low density lipoprotein particles is strongly associated with coronary heart disease in Japanese men, independently of intermediate density lipoprotein or low-density lipoprotein. Coron Artery Dis. 2002; 13:255-62.

Mallbris L, Granath F, Hamsten A, Mona S. Psoriasis is associated with lipids abnormalities at the onset of skin disease. J Am Acad Dermatol. 2006; 54(4): 614-21.

Rocha -Pereira P, Santos -Silva A, Rebelo I, Figueiredo A, Quintaniiha A, Teixeria F. Dyslipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clin Chim Acta. 2001; 303:33-9.

Piskin S, Gurkok F, Ekuklu G, Senol M. Serum lipid levels in Psoriasis. Yonsei Med J. 2003; 44:24-6.

Uyanik BS, Ari Z, Onur E, Gunduz K, Tanulku S, Durkan K. Serum lipids and apolipoproteins in patients with psoriasis. Clin Chem Lab Med. 2

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). The COVID-19 pandemic. International Journal of Health Sciences, 5(2), vi-ix. https://doi.org/10.53730/ijhs.v5n2.2937

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2022). Post-pandemic health and its sustainability: Educational situation. International Journal of Health Sciences, 6(1), i-v. https://doi.org/10.53730/ijhs.v6n1.5949

Published

06-06-2022

How to Cite

Kanakareddi, B., Chukkanakal, J. L., Narayanamurthy, A. K., & Senapathi, P. (2022). A cross sectional study of psoriasis and its association with lipid profile among the patients in a tertiary care centre. International Journal of Health Sciences, 6(S1), 13806–13812. https://doi.org/10.53730/ijhs.v6nS1.8498

Issue

Section

Peer Review Articles